Deerfield Management Company, L.P. (Series C) Sana Biotechnology, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	BUY	$2.8 - $4.55 $35,084 - $57,011	12,530 New	12,530 $51,000

Others Institutions Holding SANA

# of Institutions

174

Shares Held

121M

Call Options Held

1.87M

Put Options Held

1.48M

Flagship Pioneering Inc. Cambridge, MA

25M
Shares

$41.3 Million
17.65% of portfolio
Vanguard Group Inc Valley Forge, PA

13.2M
Shares

$21.8 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11M
Shares

$18.2 Million
0.0% of portfolio
Baillie Gifford & CO

10.3M
Shares

$17 Million
0.03% of portfolio
Canada Pension Plan Investment Board Toronto Ontario, A6

10.2M
Shares

$16.8 Million
0.04% of portfolio

View Full List

About Sana Biotechnology, Inc.

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $314M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

More about SANA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account